このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

SciBase Holding マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Pia Renaudin

最高経営責任者

SEK 648.0k

報酬総額

CEO給与比率	77.8%
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	9.4yrs
取締役会の平均在任期間	7.3yrs

経営陣の近況

Recent updates

CEO報酬分析

SciBase Holding の収益と比較して、Pia Renaudin の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	-SEK 56m
Dec 31 2023	SEK 648k	SEK 504k	-SEK 56m

報酬と市場: Piaの総報酬 ($USD 62.10K ) は、 Swedish市場 ($USD 257.80K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Piaの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Pia Renaudin (57 yo)

less than a year

在職期間

SEK 648,000

報酬

Ms. Pia Renaudin serves as Chief Executive Officer at SciBase Holding AB (publ) since October 01, 2023 SciBaseHe served as Chief Executive Officer at Senzime AB (publ) since February 08, 2019 until May 03,...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Pia Renaudin	Chief Executive Officer	less than a year	SEK 648.00k	データなし
Stig Ollmar	Founder & Chief Scientific Officer	26.4yrs	データなし	データなし
Michael Colérus	Chief Financial Officer	10.4yrs	SEK 272.54k	データなし
Per Svedenhag	Head of Business Development & Marketing	9.4yrs	SEK 1.43m	データなし
Tobias Bergenblad	Global Sales Director	9.4yrs	データなし	データなし
Leda Beaty	Head of US Commercial Operations	no data	データなし	データなし

9.4yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: SCIBの経営陣は経験豊富で経験豊富です（平均在職期間は9.4年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Thomas Taapken	Independent Director	7.1yrs	SEK 150.00k	データなし
Matt Leavitt	Independent Director	3.1yrs	SEK 150.00k	データなし
Per Nordberg	Deputy Director	7.4yrs	データなし	データなし
Jesper Hoiland	Chairman of the Board	no data	データなし	データなし
Allan Halpern	Member of Scientific Advisory Board	9.2yrs	データなし	データなし
Scott Menzies	Member of Scientific Advisory Board	9.2yrs	データなし	データなし
Diana Ferro	Independent Director	7.1yrs	SEK 150.00k	データなし
David Elder	Member of Scientific Advisory Board	9.2yrs	データなし	データなし
Josep Malvehy	Member of Scientific Advisory Board	9.2yrs	データなし	データなし
Holger Hänßle	Member of Scientific Advisory Board	9.2yrs	データなし	データなし
Robert Molander	Director	no data	データなし	データなし
Jvalini Dwarkasing	Independent Director	2.8yrs	SEK 150.00k	データなし

7.3yrs

平均在職期間

61.5yo

平均年齢

経験豊富なボード: SCIBの取締役会は経験豊富であると考えられます ( 8.3年の平均在任期間)。

SciBase Holding マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

SciBase Holding AB (publ) Announces Executive Changes

Recent updates

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

Consensus EPS estimates upgraded to kr0.22 loss, revenue downgraded

New minor risk - Profitability

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2026

New major risk - Shareholder dilution

Scibase Announces the Launch of Ebarrier Score, the First Ai-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing

New minor risk - Shareholder dilution

Price target decreased by 13% to kr1.68

SciBase Holding AB (publ) has completed a Composite Units Offering.

Consensus EPS estimates upgraded to kr0.27 loss

Consensus revenue estimates fall by 11%

New major risk - Financial position

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 39% to kr4.30

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

SciBase Holding AB (publ) to Report Fiscal Year 2023 Results on Feb 21, 2024

SciBase Holding AB (publ) to Report Q1, 2024 Results on May 09, 2024

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

New major risk - Market cap size

SciBase Holding AB Announces the Publication of A Collaborative Scientific Project with the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

Consensus EPS estimates fall by 33%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) Announces Executive Changes

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to kr0.30 loss, revenue downgraded

Full year 2022 earnings: EPS misses analyst expectations

SciBase Holding AB (publ) to Report Nine Months, 2023 Results on Nov 10, 2023

Price target decreased to kr11.00

SciBase Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 23, 2023

SciBase Holding AB (publ) Announces New Study Shows Nevisense Significantly Improves US Clinician's Decision-Making Beyond Dermoscopy

SciBase Holding AB (publ), Annual General Meeting, May 18, 2023

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

SciBase Holding AB Announces Nevisense Detects Skin Barrier Damage in Mice Caused by Household Detergents

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

SciBase Holding AB (publ) Announces US Study Shows That EIS and Nevisense Significantly Improves Clinicians' Diagnostic Accuracy

Will SciBase Holding (STO:SCIB) Spend Its Cash Wisely?

SciBase Holding AB (publ) Study Shows Clinical Benefit of Nevisense

Full year 2021 earnings released: kr0.67 loss per share (vs kr1.12 loss in FY 2020)

CEO & President recently bought kr76k worth of stock

Independent Chairman recently bought kr504k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer recently bought kr111k worth of stock

Third quarter 2021 earnings released: kr0.13 loss per share (vs kr0.20 loss in 3Q 2020)

We're Hopeful That SciBase Holding (STO:SCIB) Will Use Its Cash Wisely

Second quarter 2021 earnings released: kr0.19 loss per share (vs kr0.38 loss in 2Q 2020)

SciBase Holding AB (publ) announced that it has received SEK 71.214109 million in funding from Van Herk Investments B.V., Ostvast Capital Management Limited, and other investors

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.54 loss in 1Q 2020)

Scibase Receives Important European MDR Certification

SciBase Holding AB (publ) Submits First Reimbursement Application to CMS in Florida

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

David Melin Resigns as Head of Product Development of SciBase AB

Full year 2020 earnings released: kr1.12 loss per share (vs kr2.38 loss in FY 2019)

Revenue beats expectations

SciBase Holding AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

Calculating The Intrinsic Value Of SciBase Holding AB (publ) (STO:SCIB)

SciBase Holding AB (publ) Announces New Study Published Validating Further Nevisense Indication, Non-Melanoma Skin Cancer

New 90-day high: kr4.85

Third quarter 2020 earnings released: kr0.20 loss per share

SciBase Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 19, 2021

Scibase Holding AB (Publ) Announces Positive Step for US Reimbursement of Nevisense

SciBase Holding Releases Next Generation Platform, Nevisense Go

New 90-day high - kr4.14

Earnings released

CEO報酬分析

マネジメント基準チェック /34